The collegiate board of the National Health Surveillance Agency (Anvisa) voted, in a meeting this Wednesday (1/19), to postpone the decision on the use and sale of Covid-19 self-tests in Brazil.
Read more:
The topic was discussed at an extraordinary meeting this afternoon. To allow the use of self-examinations, Anvisa asked the Ministry of Health to formalize a public policy on the subject. In a letter sent to the agency on January 14, the Ministry of Health cited technical aspects of the use of self-examinations.
However, in the document, the federal agency did not include the use of the products in a public policy to detail the functioning of the exams, an action required by Anvisa. According to the agency, there is a lack of information on the use of the products by lay patients and on the notification of results to the Federal Government’s National Health Data Network.
